title: [Role of pemetrexed in the treatment of advanced non-small-cell lung cancer: news from ASCO, 2008].
authors.affiliation: UO di Pneumologia Oncologica I, Dipartimento di Malattie Polmonari, Azienda Ospedaliera San Camillo-Forlanini, Roma.
authors.forename: Filippo
authors.initials: F
authors.lastname: de Marinis
authors.forename: Serena
authors.initials: S
authors.lastname: Ricciardi
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D018287:Carcinoma, Large Cell / Q000188:drug therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D005971:Glutamates / Q000009:adverse effects / Q000627:therapeutic use*; D006147:Guanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D000068437:Pemetrexed; D012955:Societies, Medical; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D005971:Glutamates; D000068437:Pemetrexed; D000068258:Bevacizumab; D006147:Guanine; D002945:Cisplatin